No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MNKD250110C1000
- 0.00
- 0.000.00%
15min DelayClose Jan 7 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest1.00Strike Price0.00Turnover3010.75%IV-84.03%PremiumJan 10, 2025Expiry Date5.26Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9778Delta0.0032Gamma1.07Leverage Ratio-0.1930Theta0.0000Rho1.05Eff Leverage0.0003Vega
Intraday
- 5D
- Daily
No Data
News
MannKind Announces Upcoming Retirement of Lauren Sabella
Express News | MannKind Expands Executive Leadership Team
Press Release: MannKind Expands Executive Leadership Team
Here's Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10
MannKind Shares Rise After Wells Fargo Begins Coverage
Leerink Partners Maintains MannKind(MNKD.US) With Buy Rating, Announces Target Price $9